Cellular and Molecular NeuroTherapies


 

Deglon_2.jpg                                 Tenenbaum_2.jpg

 

Prof Nicole Déglon                                       Dr Liliane Tenenbaum

Assoc. Professor                                                      Senior Lecturer
Head of laboratory, Head of CRN                             Group Leader
 

Laboratory’s activity

The laboratory’s activities are focusing on the development and validation of innovative neurotherapies and neuromodulation strategies. The three principal investigators are focusing on:
> Modulation of neuroinflammation and drug-inducible gene therapy of Parkinson’s disease.
> Underlying molecular and environmenental mechanisms in Huntington’s disease (HD).
> Pre-clinical development of molecular therapies for Huntington’s disease (HTT gene editing).

Additional information: UNIL web site

 

 

Bâtiment Champ de l'Air - Rue du Bugnon 21 - CH-1011 Lausanne
Switzerland
Tel. +41 21 314 96 57
Centre Hospitalier Universitaire Vaudois (CHUV)